Giovanni De Sabbata

High Levels of Circulating Tumor Plasma Cells as a Key Hallmark of Aggressive Disease in Transplant-Eligible Patients With Newly Diagnosed Multiple Myeloma

Luca Bertamini, Stefania Oliva, Delia Rota‐Scalabrini et al. · Journal of Clinical Oncology · 2022 · 79 citations · Full text

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

Paola Tacchetti, Lucia Pantani, Francesca Patriarca et al. · The Lancet Haematology · 2020 · 57 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +12

Persistent viremia and urine shedding of tick-borne encephalitis virus in an infected immunosuppressed patient from a new epidemic cluster in North-Eastern Italy

Ilaria Caracciolo, Matteo Bassetti, G Paladini et al. · Journal of Clinical Virology · 2015 · 50 citations

Vector-borne Pathogen, New Epidemic Cluster, Pathogenesis +8

Survival Analysis of Newly Diagnosed Transplant-Eligible Multiple Myeloma Patients in the Randomized Forte Trial

Francesca Gay, Pellegrino Musto, Delia Rota Scalabrini et al. · Blood · 2020 · 44 citations

Methotrexate and cyclosporin combined therapy in severe psoriatic arthritis. A pilot study.

G Mazzanti, L. Coloni, Giovanni De Sabbata et al. · PubMed · 1994 · 36 citations

Rheumatology, Autoimmune Disease, Medicine +9